AusPAR: Glecaprevir / pibrentasvir

Australian Public Assessment Report

AusPAR

AusPAR: Glecaprevir / pibrentasvir [PDF, 1.55 MB]

AusPAR: Glecaprevir / pibrentasvir [Word, 2.89 MB]

Attachment: Product Information: Glecaprevir / pibrentasvir [PDF, 355.3 KB]

Attachment: Product Information: Glecaprevir / pibrentasvir [Word, 111.27 KB]

Attachment: Extract from Clinical Evaluation: Glecaprevir / pibrentasvir [PDF, 1.31 MB]

Attachment: Extract from Clinical Evaluation: Glecaprevir / pibrentasvir [Word, 3.01 MB]

Device/Product Name

Maviret

Active ingredients

Glecaprevir / pibrentasvir

AusPAR Date

6 November 2018

Published

23 January 2019

Submission Number

PM-2017-00210-1-2

Submission Type

New chemical entity

Decision

Approved